WHO set to restart Sputnik COVID-19 vaccine analysisA picture taken on December 4, 2020 shows the production of Russia's Gam-COVID-Vac vaccine against the coronavirus disease (Covid-19) registered under trade name Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology in coordination with the Russian Defence Ministry, at the facility of Russia's biotech company BIOCAD in Strelna outside Saint Petersburg. GENEVA, Switzerland — The World Health Organization said on Thursday it was about to restart the process of approving Russia's Sputnik V Covid-19 vaccine following a series of problems with the dossier. Several Covid-19 vaccines have been given the WHO green light for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca in various plants. In June, the WHO said it conducted nine inspections of Sputnik V manufacturing sites and uncovered various problems at the Pharmstandard Ufa Vitamin Plant in Ufa, southern Russia. Several Russian vaccines including Sputnik V have been available for months, but authorities have struggled to immunise a vaccine-sceptic population.

Source: Philippine Star October 07, 2021 22:41 UTC